FM
Francesco Marchesi
Research areas: Medicine · Oncology · Neutropenia and Cancer Infections · COVID-19 Clinical Research Studies · COVID-19 and healthcare impacts
0000-0001-6353-2272
Employment
Employment history is unavailable.
Education
Education history is unavailable.
Projects & Funding
Projects & funding information is unavailable.
Publications (179)
- Nursing Educational Interventions for Oncohaematological Patients Undergoing Autologous Stem Cell Transplantation and Their Caregivers: A Mixed-Methods Systematic Review Save
- Real‐Life Study on Gilteritinib‐Related Infections ( <scp>GilteRInf</scp> ): An Italian <scp>SEIFEM</scp> Study Save
- Treatment and outcome of chronic disseminated candidiasis in the era of antifungal prophylaxis: a retrospective multicentre cohort of 111 patients Save
- Characterization of FLT3-ITD-mutated leukemic stem cells: functional and clinical insights Save
- Efficacy and Potential Limitation of the Menin Inhibitor Revumenib Outside Clinical Trials: Extramedullary Response with Central Nervous System Escape in a Case of KMT2A-Rearranged Acute Myeloid Leukemia Save
- Antibacterial, antifungal and antiviral prophylaxis and vaccination strategies in adult patients with acute myeloid and promyelocytic leukemia: An expert panel consensus from the GIMEMA group Save
- Characteristics and Outcomes of Progressive Multifocal Leukoencephalopathy in Hematologic Malignancies: A <scp>SEIFEM</scp> Retrospective Review Save
- Editorial: Multidrug-resistant Gram-negative bacteria in fragile hosts Save
- Underrated, Unvaccinated, Untreated: A Multinational Registry Analysis of Human Metapneumovirus in Hematological Malignancy, Insights From EPICOVIDEHA/EPIRESEHA Registry Save
- OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES Save
- Impact of fitness categorization according to SIE/SIES/GITMO criteria in therapy-related and AML-MRC receiving CPX-351 Save
- Beyond the Usual Suspects: RSV Infection in Patients With Hematological Malignancies Compared to Influenza and SARS‐COV‐2—A Report From the EPICOVIDEHA/EPIRESEHA Registry Save
- Nuclear respiratory factor 1 promotes cell survival in multiple myeloma under proteasome inhibition therapy Save
- Gilteritinib in FLT3‐mutated acute myeloid leukemia: A real‐world Italian experience Save
- A predictive serum <scp>miRNA</scp> signature impacts diffuse large B‐cell lymphoma cell viability via inhibition of <scp>EGLN1</scp> and <scp>TXNRD1</scp> regulators of ferroptosis Save
- Author’s Reply to the correspondence: ECIL-10 guidelines for COVID-19 should take convalescent plasma into proper consideration by Focosi et al. Save
- Post-pandemic recommendations for the management of COVID-19 in patients with haematological malignancies or undergoing cellular therapy, from the European Conference on Infections in Leukaemia (ECIL-10) Save
- Matching-adjusted indirect comparison of CPX- 351 in secondary Acute Myeloid Leukemia between the registrative trial and a real-life study Save
- Anti-CD20 maintenance strategies to face the challenge of COVID-19 pandemic in follicular lymphoma: results from the R-FolSTOP multicentre Italian study Save
- Elevating fungal care: bridging Brazil’s healthcare practices to global standards Save